1.Congenital Dislocation of Hip in Twin Babies: A case report
Myung Sang MOON ; In KIM ; Ho KANG ; Soon Ok AHN
The Journal of the Korean Orthopaedic Association 1977;12(1):47-50
Congenital dislocation of the hip has been known as one of the most common congenital anomalies in the orthopedic field since the time of Hippocrates (460-357 B.C.). The occurence of C.D.H. in twin babies is extremely rare thus few if any papers have been reported. During the period of January 1971 through June 1976 the authors have treated a total of 49 cases as inpatients. Two of these were twin babies. In both cases the hip was surgically reduced and followed by open reduction and femoral derotation osteotomy. Clinically and radiologically the results were good during the duration of follow-up seven months after operations.
Dislocations
;
Follow-Up Studies
;
Hip
;
Humans
;
Inpatients
;
Orthopedics
;
Osteotomy
;
Twins
2.Two cases of pulmonary lymphangioleiomyomatosis associated with tuberous sclerosis.
Jeong Cheon AHN ; Weon Yong JOH ; Kwang Ho IN ; Kyung Ho KANG ; Se Hwa YOO
Tuberculosis and Respiratory Diseases 1992;39(6):542-547
No abstract available.
Lymphangioleiomyomatosis*
;
Tuberous Sclerosis*
3.Efficacy of Fluvastatin in Patients with Hypercholesterolemia
Moon Ho KANG ; Sung Gwang LEE ; Jung Ho YOUN ; Tae Suk KIM ; Seung Woon AHN
Journal of Korean Society of Endocrinology 1996;11(1):75-84
Background: Fluvastatin is the first entirely synthetic 3-hydroxy-3-methylglutaryl-coenzyme A(HMG-CoA) reductase inhibitor. Clinical data indicate that this agent exhibits the proven efficacy of its class and also has some theoretical advantages in safety for long-term use because of its unique pharmacololgic property consistent with hepatoselectivity(i.e., low systemic exposure). This study is to evaluate efficacy and safety of fluvastatin in hypercholesterolemic patients in Korea. Methods: An open clinical trial with fluvastatin was conducted in 31 subjects who continued to have high blood cholesterol levels of 6.21 mmol/L(240 mg/dl) or greater after 1 month of lipid-lowering diet plus single blind placebo period. Fluvastatin was administered for 8 weeks with the initial dose of 20 mg per day and if serum cholesterol levels did not fall below 5.20 mmol/L(200 mg/dl) after 4 weeks the dose was increased to 40 mg per day for the second 4 weeks. On each visit every 4 weeks they underwent interview and laboratory tests about side effects and tolerability. Results: The mean % changes in plasma total cholesterol and LDL-cholesterol from baseline were
Cholesterol
;
Creatine Kinase
;
Diet
;
Humans
;
Hypercholesterolemia
;
Korea
;
Oxidoreductases
;
Plasma
;
Sleep Stages
;
Triglycerides
4.Congenital Cytomegalovirus infection.
Kang Woo PARK ; Ho Seek AHN ; Eui Bon KOO ; Sung Won KIM ; Kil Hyun KIM
Journal of the Korean Pediatric Society 1990;33(9):1271-1275
No abstract available.
Cytomegalovirus Infections*
;
Cytomegalovirus*
5.A Case of Benign Ovarian Steroid Cell Tumor with Huge Ascites and Elevated Serum CA125.
Ho Jin CHAE ; Sung Hong YANG ; Young Do AHN ; Ki Heung KIM ; Gi Joo KANG
Korean Journal of Gynecologic Oncology and Colposcopy 1999;10(3):300-305
Steroid cell tumor of ovary, first described as lipid cell tumor, is rare lesions composed entirely of cells resembling typical steroid hormone - secreting cells, that is lutein cells, Leydig cells, and adrenal cortical cells. Steroid cell tumors oftcn secret androgen and manifest themselves with symptoms of virilization. Other presentations include abdominal swelling or pain, menstrual dysfunction, postmenopausal bleeding, or rarely ascites. We experienced a case of right ovarian steroid cell tumor, not otherwise specified(NOS), manifested hirsuitism and amenorrhea in 49 - year - old patient. The tumor was about 5 cm in size, and associated with huge ascites (l3,000 ml), both pleural effusion, and elevated serum CA 125. We present a case of Meigs syndrome associated with benign ovarian steroid cell tumor with a brief review of the literature.
Amenorrhea
;
Ascites*
;
Dysmenorrhea
;
Female
;
Hemorrhage
;
Humans
;
Leydig Cells
;
Luteal Cells
;
Male
;
Meigs Syndrome
;
Ovary
;
Pleural Effusion
;
Virilism
6.Esophageal complex reconstruction for corrosive esophagitis complicated with gastric outlet obstruction:2 case.
Jeong Soo KIM ; Keun Ho LEE ; Chang Joon AHN ; Rae Sung KANG
Journal of the Korean Surgical Society 1993;44(2):294-300
No abstract available.
Esophagitis*
7.Santonin-kainic acid complex as a mass chemotherapeutic of Ascaris lumbricoides control in Korea.
Soon Hyung LEE ; Se Chul KANG ; Jong Ho AHN ; Jung Woo LEE ; Han Jong RIM
The Korean Journal of Parasitology 1972;10(2):79-85
Santonin-kainic acid complex was evaluated as a chemotherapeutic of the mass treatment of the Ascaris lumbricoides infection in Korea. The results could be summarized as follows: The negative conversion rate was 82.9% in average in 4 treated groups. Some variations of negative conversion rate among the treated groups were noticed. The egg reduciton rate was 97.7% in average and the results were rather uniform among the three evaluated groups. By the analysis of egg reduction, it seems that the lightly infected cases whose E.P.G. were under 5,000 were resistant to treatment with the less reduced egg output. After the treatment with this complex, the number of egg discharged cases were reduced to 1.84% and the average number of discharge eggs per incompletely treated or untreated cases were reduced to 12.5% compared with the level of before-treatment egg output. The successive observations of the pattern of worm expulsion after drug intake was made. The worms were mostly expelled in the stool within 3 days, and 58.9% of total expelled worms were collected within 24-hour stool. The minimum length of the immature worms expelled was 7.6cm. Among the 659 Ascaris collected in the first-day stool from 91 rural people, 8.5% were in the range of 7.6-12.2 cm-long, immature worms. The sex ratio, male: female= 0.69: 1.
parasitology-helminth-nematoda
;
Ascaris lumbricoides
;
chemotherapy
;
Santonin
;
kainic acid
8.Prevalence and clinical characteristics of the anti-HCV positive patients who had invreased transaminase levels with negative HBsAg.
Eun Joo AHN ; Tae Ho CHUNG ; Hee Chul KANG ; Chul Young BAE ; Dong Hak SHIN
Journal of the Korean Academy of Family Medicine 1992;13(1):72-78
No abstract available.
Hepatitis B Surface Antigens*
;
Humans
;
Prevalence*
9.Prevalence and Molecular Genetic Characteristics of Vibrio parahaemolyticus New 03:K6 and 04:K68.
Tae Yeal CHOI ; Won Ho CHAE ; Duk Un KIM ; Jung Oak KANG ; Hyunjoo PAI ; Youhern AHN
Korean Journal of Nosocomial Infection Control 2005;10(2):48-56
BACKGROUND: Vibrio parahaemolyticus belonged to the new 03:K6 serotype was demonstrated an unusual potential to spread and an enhanced propensity to cause infection in the worldwide. Recently, increased numbers of V. parahaemolyticus 03:K6 had been isolated in Korea, and we analyzed the prevalence and molecular genetic characteristics of V. parahaemolyticus 03:K6 isolates. METHODS: V. parahaemolyticus were isolated from clinical specimens of patients with diarrhea in Hanyang University Hospital, Seoul, Korea, from 1998 to 2005. The serovars of isolates were determined by slide agglutination test with specific antisera. All isolates were examined for the presence of tdh/trh genes. AGS-PCR method detecting the new 03:K6 clone was used in this study. We analyzed clonality of these isolates by infrequent restriction site-polymerase chain reaction (IRS-PCR). RESULTS: Thirty-six strains were isolated from 1998 to 2005. The main serotype of isolates were 03:K6 (24/36: 67%), All of them have tdh gene but not trh gene and an unique toxRS gene of the new 03:K6. The morphotypes of 03:K6 isolates show a same pattern of IRS-PCR, but can easily be differentiated from non-03:K6 and 04:K68 isolates. CONCLUSION: The 03:K6 was a main serotype of V. parahaemolyticus isolated from 1998 to 2005 and they show same molecular characteristics.
Agglutination Tests
;
Clone Cells
;
Diarrhea
;
Humans
;
Immune Sera
;
Korea
;
Molecular Biology*
;
Prevalence*
;
Seoul
;
Vibrio parahaemolyticus*
;
Vibrio*